新型指标与急性心肌梗死预后的研究进展

摘要/Abstract

摘要： 急性心肌梗死是全球心血管疾病发病率和病死率的主要原因。尽管遵循当前指南推荐的治疗方法,急性心肌梗死患者仍容易复发心血管事件。因此,如何运用便捷且高效的化验检测指标对急性心肌梗死患者的残余风险进行早期发现和干预对改善预后具有重要意义。近年来,关于评价急性心肌梗死患者预后的指标研究日益增多,取得了许多新进展。本文综述了近年来国内外在评价急性心肌梗死预后反映全身炎症与代谢紊乱方面的新指标研究：血浆致动脉硬化指数;脂蛋白（a）;全身免疫炎症指数;系统性炎症反应指数;甘油三酯-葡萄糖指数,旨在为临床实践提供新的参考和依据。

关键词: 血浆致动脉硬化指数, 脂蛋白（a）, 全身免疫炎症指数, 系统性炎症反应指数, 甘油三酯-葡萄糖指数

童腾, 刘思管. 新型指标与急性心肌梗死预后的研究进展[J]. 心血管病防治知识, 2026, 16(6): 138-144.

参考文献

[1] Dobiásová M,Frohlich J.The plasma parameter log (TG/HDL-C) as an atherogenic index:correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER (HDL))[J]. Clin Biochem,2001,34(7):583-588.
[2] Cure E,Icli A,Uslu A U,et al.Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS[J]. Clin Rheumatol,2018,37(5): 1273-1280.
[3] Natarajan P,Ray K K,Cannon C P.High-density lipoprotein and coronary heart disease: current and future therapies[J]. J Am Coll Cardiol,2010,55(13):1283-1299.
[4] Kammar-García A,López-Moreno P,Hernández-Hernández M E,et al. Atherogenic index of plasma as a marker of cardiovascular risk factors in Mexicans aged 18 to 22 years[J]. Proc (Bayl Univ Med Cent),2020,34(1):22-27.
[5] Kanonidou C.Small dense low-density lipoprotein: Analytical re-view[J]. Clin Chim Acta,2021,520:172-178.
[6] Ikezaki H,Lim E,Cupples L A,et al.Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study[J]. J Am Heart Assoc,2021,10(5):e19140.
[7] 蒋雯禧,谷凌云,徐卓文,等.TyG、AIP指数与非糖尿病AMI病人PCI术后发生的相关性[J]. 中西医结合心脑血管病杂志,2024,22(21):3964-3968.
[8] Sadeghi M,Heshmat-Ghahdarijani K,Talaei M,et al.The predictive value of atherogenic index of plasma in the prediction of cardiovascular events; a fifteen-year cohort study[J]. Adv Med Sci,2021,66:418-423.
[9] Rokicka D,Hudzik B,Wróbel M,et al.Prognostic value of novel atherogenic indices in patients with acute myocardial infarction with and without type 2 diabetes[J]. J Diabetes Complications,2024,38(10):108850.
[10] Ma X,Sun Y,Cheng Y,et al.Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention[J]. Lipids Health Dis,2020,19:240.
[11] Wang Y,Wang S,Sun S,et al.The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8 mmol/L[J]. Cardiovasc Diabetol, 2023,22:150.
[12] Jiang Y. Atherogenic index of plasma and cardiovascular outcomes in female patients undergoing percutaneous coronary intervention: insights from a retrospective cohort study[J]. Sci Rep, 2025,15(1):3112. Published 2025 Jan 24.
[13] 张罡. 急性心肌梗死(AMI)患者行PCI后1年内发生不良心血管事件的危险因素及预测价值[D]. 内蒙古医科大学,2024.
[14] 郑朝霞,牛福英,李晴,等.AIP、hs-CRP、NT-proBNP对急性心肌梗死新发心力衰竭的早期预测价值[J]. 中国分子心脏病学杂志,2023,23(6):5790-5795.
[15] Erqou S,Kaptoge S,et al.White IR,et al. Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease,stroke,and nonvascular mortality[J]. JAMA,2009,302(4):412-23.
[16] Tsimikas,S.A Test in Context: Lipoprotein (a): Diagnosis, Prognosis, Controversies, and Emerging Therapies[J]. J. Am. Coll. Cardiol, 2017,69,692-711.
[17] Tsimikas S, Fazio S, Ferdinand KC, et al.Working Group Recommendations to Reduce Lipoprotein (a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. J. Am. Coll. Cardiol. 2018,71,177-192.[18]Clarke R,Peden JF,Hopewell JC,Kyriakou T,Goel A,Heath SC,et al. Consortium. Genetic variants associated with Lp(a) lipoprotein level and coronary disease[J]. N Engl J Med, 2009;361:2518-28.
[18] Clarke R,Peden JF,Hopewell JC,Kyriakou T,Goel A,Heath SC,et al.PROCARDIS Consortium. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.N Engl J Med 2009,361:2518-28.
[19] 胡驰. Lp(a)与行PCI术的AMI患者冠脉病变程度的关系及对近期预后的影响[D]. 川北医学院,2022.
[20] Buciu IC,Tieranu EN,Pircalabu AS,et al. The Relationship between Lipoprotein A and the Prevalence of Multivessel Coronary Artery Disease in Young Patients with Acute Myocardial Infarction: An Observational Study[J]. Biomedicines,2024,12(9):2159. Published 2024 Sep 23.
[21] 张琳. Lp(a)对中青年AMI预测价值及其冠脉狭窄程度相关性研究[D]. 长春中医药大学,2024.
[22] 刘影,潘三葱,崔花花,等.Lp(a)与急性心肌梗死患者经皮冠状动脉介入治疗术后复发心血管不良事件的相关性研究[J]. 临床和实验医学杂志,2025,24(5):453-457.
[23] Mitsuda T,Uemura Y,Ishii H,et al.Lipoprotein(a) levels predict adverse vascular events after acutemyocardial infarction[J]. Heart Vessels, 2016,31(12):1923-1929.
[24] Hu B,Yang XR,Xu Y,et al.Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014,20(23):6212-22.
[25] Wang Z,Qin Z,Yuan R,et al.Systemic immune-inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction[J]. ESC Heart Fail, 2023, 10(1):478-91.
[26] Xu M,Chen R,Liu L,et al.Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study[J]. Atherosclerosis, 2021,323:20-9.
[27] Rurik JG,Aghajanian H,Epstein JA.Immune cells and immunotherapy for cardiac injury and repair[J]. Circ Res, 2021,128(11):1766-79.
[28] Aksakal E,Aksu U,Birdal O,et al.Role of systemic immune-inflammatory index in predicting the development of in-hospital malignant ventricular arrhythmia in patients with ST-elevated myocardial infarction[J]. Angiology, 2022,74:881.
[29] Dolu AK,Karayiğit O,Ozkan C,et al.Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment elevation myocardial infarction[J]. ActaCardiol, 2023,78(1):72-9.
[30] Orhan AL,Şaylık F,Çiçek V,et al.Evaluating the systemic immune inflammation index for in-hospital and long-term mortality in elderly non-ST-elevation myocardial infarction patients[J]. Aging Clin Exp Res, 2022,34(7):1687-95.
[31] 艾丽菲热·艾海提,马艺萍,刘柯,等.全身免疫炎症指数与急性心肌梗死患者再灌注后发生室性心律失常的关联性分析[J]. 中国心血管病研究,2024,22(9):769-774.
[32] 林惠,夏亚楠,刘湘国,等.全身免疫炎症指数与急性心肌梗死合并心源性休克患者院内结局的相关性分析[J]. 实用休克杂志(中英文),2025,9(2):87-90,96.
[33] Li Q,Ma X,Shao Q,et al.Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients[J]. Front Cardiovasc Med, 2022,9:811790.
[34] 王之文,吴思,蔡东东,等.全身免疫炎症指数对急性心肌梗死患者远期不良心脑血管事件的预测价值研究[J]. 中国循证心血管医学杂志,2025,17(7):870-873,877.
[35] Luo J,Qin X,Zhang Xet al. -SH Registry Investigators. Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the -SH registry[J]. Cardiovasc Diabetol, 2024 Jan 22,23(1):41.
[36] 简郭进,张斌,朱杰.系统免疫炎症指数对急性心肌梗死患者新发房颤的预测效能[J]. 山东医药,2022,62(23):55-57
[37] Wang H,Liu Z,Shao J,et al.Immune and inflammation in acute coronary syndrome: Molecular mechanisms and therapeutic implications[J]. J Immunol Res, 2020,2020:4904217.
[38] Akrami M,Izadpanah P,Bazrafshan M,et al.Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence: A randomized placebo-control trial[J]. BMC Cardiovasc Disord, 2021,21(1):583.
[39] Niu Y,Bai N,Ma Y,et al.Safety and efficacy of anti-inflammatory therapy in patients with coronary artery disease: A systematic review and meta-analysis. BMC Cardiovasc Disord.2022,22(1):84.
[40] Kounis NG,Soufras GD,Tsigkas G,et al.White blood cell counts,leukocyte ratios,and eosinophils as inflammatory markers in patients with coronary artery disease[J]. Clin Appl Thromb Hemost, 2015,21(2):139-143.
[41] Fernández-Ruiz I.Neutrophil-driven SMC death destabilizes atherosclerotic plaques[J]. Nat Rev Cardiol, 2019,16(8):455-455.
[42] Shah AD,Denaxas S,Nicholas O, et al.Neutrophil counts and initial presentation of 12 cardiovascular diseases[J]. J Am Coll Cardiol, 2017,69(9): 1160-1169.
[43] Weber C,Zernecke A,Libby P.The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models[J]. Nat Rev Immunol, 2008,8(10):802-815.
[44] Ommen SR,Gibbons RJ,Hodge DO, et al.Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease[J]. J Am Coll Cardiol, 1997,79(6):812-814.
[45] Núñez J,Núñez E,Bodí V,et al.Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction[J]. Coron Artery Dis,2010,21(1):1-7.
[46] Gratchev A,Sobenin I,Orekhov A,Kzhyshkowska J.Monocytes as a diagnostic marker of cardiovascular diseases[J]. Immunobiology,2012,217(5):476-482.
[47] Wu MY,Li CJ,Hou MF, et al.New insights into the role of inflammation in the pathogenesis of atherosclerosis[J]. Int J Mol Sci,2017,18(10):2034.
[48] Berg KE,Ljungcrantz I,Andersson L,et al.Elevated CD14++ CD16 monocytes predict cardiovascular events[J]. Circ Cardiovasc Genet, 2012,5(1):122-131.
[49] 王峰,路石万,李秀诗,等.全身炎症反应指数与冠心病患者PCI术中发生慢血流或无复流的相关性分析[J]. 遵义医科大学学报,2025,48(11):1132-1140.
[50] Xia Y,Xia C,Wu L,et al.Systemic immune inflammation index (SII),system inflammation response index () and risk of all-cause mortality and cardiovascular mortality: A 20-year follow-up cohort study of 42,875 US adults[J]. J Clin Med, 2023,12(3):1128.
[51] Jin Z,Wu Q,Chen S,et al.The associations of two novel inflammation indexes,SII and with the risks for cardiovascular diseases and all-cause mortality: A ten-year follow-up study in 85,154 indivduals[J]. J Inflamm Res, 2021,14:131-140.
[52] Dziedzic EA,Gąsior JS,Tuzimek A,et al.Investigation of the associations of novel inflammatory biomarkers - systemic inflammatory index (SII) and systemic inflammatory response index () with the severity of coronary artery disease and acute coronary syndrome occurrence[J]. Int J Mol Sci, 2022,23(17):9553.
[53] Lin KB,Fan FH,Cai MQ,et al.Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke[J]. Eur J Med Res, 2022,27(1):106.
[54] Li Q,Ma X,Shao Q,et al.Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients[J]. Front Cardiovasc Med, 2022,9: 811790.
[55] Ma M,Wu K,Sun T,et al.Impacts of systemic inflammation response index on the prognosis of patients with ischemic heart failure after percutaneous coronary intervention[J]. Front Immunol,2024,15:1324890.
[56] Buerke M,Lemm H,Dietz S,et al.Pathophysiology,diagnosis,and treatment of infarction-related cardiogenic shock[J]. Herz Mar. 2011,36(2):73-83.
[57] Wiggers H,Nørrelund H,Nielsen SS,et al.Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium[J]. Am J Physiol Heart Circ Physiol Aug, 2005,289(2):H938-46.
[58] Kaplangoray M,Toprak K,Başanalan F et al. May. Investigation of the relationship between triglycerides-glucose İndex andcoronary slow flow:a retrospective case-control study[J]. Arq Bras Cardiol, 2023,120(6):e20220679.
[59] Kaplangoray M, Toprak K, Başanalan F,et al.Investigation of the Relationship Between Triglycerides-Glucose İndex and Coronary Slow Flow: A Retrospective Case-Control Study[J]. Arq Bras Cardiol, 2023,120(6):e20220679.
[60] Yu B,Mo Y,Hu X,et al.Triglyceride-glucose index is associated with quantitative flow ratio in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention[J]. Front Cardiovasc Med, 2022,9:1002030.
[61] Li Y,Yi M,Wang X,et al.Association between triglyceride-glucose index and endothelial dysfunction[J]. Endocr Aug, 2024,85(2):717-23.
[62] Bulut M,Celik FB,Guvenc TS,et al.Usefulness of triglyceride-glucose index and homeostatic model assessment for predicting coronary microvascular dysfunction[J]. J Clin Lipidol May,2024:6.
[63] Sungono V, Hariyanto H, Soesilo TEB,et al. Cohort study of the APACHE II score and mortality for different types of intensive care unit patients[J]. Postgrad Med J, 2022 Dec 1,98(1166):914-918.
[64] Kellner P,Prondzinsky R,Pallmann L,et al.Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI: II, III, Elebute-Stoner,,and II[J]. Med Klin Intensivmed Notfmed Nov, 2013, 108(8): 666-674.
[65] Ye Z,Xu Y,Tang L,et al.Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model[J]. Cardiovasc Diabetol Apr, 2023,13(1):87.
[66] 祁珊珊,李博涵,童睿,等.甘油三酯-葡萄糖指数对急性心肌梗死患者合并心律失常的预测价值(J).陕西医学杂志,2025,54(10):1337-1342.
[67] 冯鹏. TyG指数与青年非糖尿病急性心肌梗死患者的相关性研究(D).南昌大学,2025.
[68] 马昕怡,谢旭东.甘油三酯-葡萄糖指数对急性心肌梗死患者院内死亡率的预测价值[J]. 暨南大学学报(自然科学与医学版),2025,46(02):185-193.
[69] 邵栗严,李玉龙,付士辉,等.甘油三酯-葡萄糖指数与老年人急性心肌梗死的关系研究[J]. 中华保健医学杂志,2024,26(4):396-398.
[70] 孙麒超. 甘油三酯葡萄糖指数对2型糖尿病合并急性心肌梗死患者住院期间再发心血管事件的预测价值[D]. 中国医科大学,2024.
[71] Hao Q,Yuanyuan Z,Lijuan C.The Prognostic Value of the Triglyceride Glucose Index in Patients With Acute Myocardial Infarction[J]. J Cardiovasc Pharmacol Ther, 2023,28:10742484231181846.
[72] Liu H,Wang L,Zhou X,et al.Triglyceride-glucose index correlates with the occurrence and prognosis of acute myocardial infarction complicated by cardiogenic shock: data from two large cohorts[J]. Cardiovasc Diabetol, 2024,23(1):337.
[73] Liu H,Wang L,Wang H,et al.Triglyceride-glucose index correlates with the incidences and prognoses of cardiac arrest following acute myocardial infarction: data from two large-scale cohorts[J]. Cardiovasc Diabetol, 2025,24(1):108.